MedX Health Corp (MDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K ≈ $-497.43K USD) by net assets (CA$-10.02 Million ≈ $-7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MedX Health Corp net asset quality index to measure how much of total assets are equity-financed.
MedX Health Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore MedX Health Corp (MDX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
MedX Health Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thai Capital Corporation Public Company Limited
BK:TCC
|
0.110x |
|
Avrasya Petrol ve Turistik Tesisler Yatirimlar AS
IS:AVTUR
|
0.010x |
|
Herkules S.A.
WAR:HRS
|
0.023x |
|
Nam Sung
KO:004270
|
-0.009x |
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
-4.279x |
|
Park Ha Biological Technology Co., Ltd.
NASDAQ:PHH
|
-12.940x |
|
NPK Co.Ltd
KQ:048830
|
0.058x |
|
Japan Vietnam Medical Instrument JSC
VN:JVC
|
0.005x |
Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see MedX Health Corp (MDX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-8.52 Million ≈ $-6.17 Million |
CA$-2.51 Million ≈ $-1.82 Million |
0.295x | -38.53% |
| 2023-12-31 | CA$-7.14 Million ≈ $-5.17 Million |
CA$-3.42 Million ≈ $-2.48 Million |
0.479x | +21.14% |
| 2022-12-31 | CA$-7.08 Million ≈ $-5.12 Million |
CA$-2.80 Million ≈ $-2.03 Million |
0.396x | -68.21% |
| 2021-12-31 | CA$-3.63 Million ≈ $-2.63 Million |
CA$-4.52 Million ≈ $-3.27 Million |
1.244x | -11.46% |
| 2020-12-31 | CA$-2.07 Million ≈ $-1.50 Million |
CA$-2.91 Million ≈ $-2.10 Million |
1.405x | +204.09% |
| 2019-12-31 | CA$-2.87 Million ≈ $-2.07 Million |
CA$-1.32 Million ≈ $-958.33K |
0.462x | -72.62% |
| 2018-12-31 | CA$-1.54 Million ≈ $-1.12 Million |
CA$-2.61 Million ≈ $-1.89 Million |
1.688x | +72.37% |
| 2017-12-31 | CA$-1.50 Million ≈ $-1.09 Million |
CA$-1.47 Million ≈ $-1.06 Million |
0.979x | +34.25% |
| 2016-12-31 | CA$-1.83 Million ≈ $-1.32 Million |
CA$-1.33 Million ≈ $-963.12K |
0.729x | +225.13% |
| 2015-12-31 | CA$-2.39 Million ≈ $-1.73 Million |
CA$-536.53K ≈ $-388.12K |
0.224x | -41.31% |
| 2014-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-864.08K ≈ $-625.06K |
0.382x | +814.58% |
| 2013-12-31 | CA$-3.40 Million ≈ $-2.46 Million |
CA$-141.94K ≈ $-102.68K |
0.042x | -- |
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more